0

Premature ovarian failure and dehydroepiandrosterone

Mamas L et al., 2008

Mamas L, Mamas E

Fertility and sterility, 91(2), 644-646, 2009

Source DOI PubMed

Abstract

Since the first successful birth at our center following treatment with DHEA in a patient with premature ovarian failure (POF), all subsequent patients with POF underwent the same treatment protocol. Receiving very encouraging results (FSH level was decreased in the first five patients and all achieved pregnancy), it was decided to study the action of DHEA for a reasonable length of time and in a larger number of patients to confirm the effectiveness of this particular therapeutic regime.

Topics

Infertility > Female Factor > Age-RelatedReproductive Endocrinology > AMH > Ovarian ReserveReproductive Endocrinology > Ovulation > Induction
dhea premature ovarian failure treatment, dehydroepiandrosterone poi supplementation, ovarian insufficiency dhea therapy, premature menopause dhea protocol, diminished ovarian reserve dhea, poi hormone supplementation outcomes, dhea infertility treatment pilot study, early ovarian failure hormone therapy, dhea ovarian function restoration, premature ovarian insufficiency treatment options

Cite this article

Mamas, L., & Mamas, E. (2008). Premature ovarian failure and dehydroepiandrosterone. *Fertility and sterility*, *91*(2), 644-646. https://doi.org/10.1016/j.fertnstert.2007.11.055

Keywords

Adult, Dehydroepiandrosterone, Estradiol, Female, Fertility Agents, Follicle Stimulating Hormone, Human, Humans, Infertility, Luteinizing Hormone, Pilot Projects, Pregnancy, Pregnancy Rate, Primary Ovarian Insufficiency, Treatment Outcome

Related articles